TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
GNTA

Genenta Science SpA

Healthcare · Biotechnology

0.6903$ +0.7% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns Genenta Science SpA (GNTA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 28.8% of the shares are freely tradable; institutional investors hold 6.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 6.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 42.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 28.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.3%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 48Mio.

Largest Shareholders

Institutions

Institutions GNTA
Name Stake (%) Shares Change (%) Date
Eurizon Capital SGR SpA 0.75 360,000 +0.0 06/30/2026
Allianz SE 0.49 234,050 +0.0 06/30/2026
SmartHarvest Portfolios, LLC 0.09 43,856 -67.4 06/30/2026

Funds

Funds GNTA
Name Stake (%) Shares Change (%) Date
Eurizon Azioni Internazionali 0.75 360,000 +0.0 08/31/2026
Mediolanum Flessibile Futuro Italia LA 0.41 198,253 +0.0 03/31/2026
QSF - Banor Global Asset Dvrs I EUR Acc 0.36 172,000 +0.0 07/31/2026
Investitori Flessibile 0.24 115,300 +0.0 08/31/2026
Investitori America 0.18 84,750 +0.0 08/31/2026
Anthilia Small Cap Italia A 0.14 69,199 +0.0 08/31/2026
Kairos Intl SICAV Italia P 0.10 50,156 +0.0 05/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?